ClinicalTrials.gg
RecruitingNCT06338969Updated Apr 3, 2024

The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Ketosis and Ketoacidosis

An interventional study of Carbohydrate Restriction after a Gastric Bypass in Obesity, Morbid, NASH and Ketosis, sponsored by The Society of Bariatric and Metabolic Surgeons of Kazakhstan. Recruiting at 1 site in Kazakhstan. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-04-03.

Sponsored by The Society of Bariatric and Metabolic Surgeons of Kazakhstan · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 7 months ago, but the record still lists the study as recruiting.
  • Started Mar 2024; still recruiting 2 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Background:

Ketosis after bariatric surgery is a metabolic process that occurs when the body breaks down fat for energy because of not getting enough carbohydrates.

Insufficient production of ketone bodies reduces the rate of weight loss, and excessive amounts of ketones can lead to ketoacidosis or liver failure in patients with nonalcoholic steatohepatitis (NASH).

The investigators hypothesize that weight loss is directly related to calorie intake, and a significant reduction in carbohydrate content leads to increased ketosis and the risk of ketoacidosis.

Objectives:

The study aimed to compare the incidence of ketoacidosis and liver failure in patients with NASH with different intakes of carbohydrates in the early postoperative period after gastric bypass. In addition, the investigators want to find out how carbohydrate restriction will affect weight loss for up to 1 year.

Read the detailed description

Methods:

This study is a three-arm randomized controlled trial. All patients will undergo laparoscopic one anastomotic gastric bypass. In the postoperative period, all patients will receive normal daily amounts of protein and fat. Depending on the amount of carbohydrates that will be received after surgery, patients will randomly (no mask) be divided into three groups:

The first group: 51-75% deficit in carbohydrates Second group: 26-50% deficit in carbohydrates The third group: has a 1-25% deficit in carbohydrates.

Primary outcome measurement Compare the incidence of ketoacidosis and liver failure in three groups of patients with NASH with different intakes of carbohydrates in the early postoperative period after gastric bypass.

Secondary outcome measurements Change in body mass index (Δ BMI). Effect weight loss for up to 1 year.

02

Conditions studied

  • Obesity, Morbid
  • NASH
  • Ketosis
  • Keto Acidosis
  • Carbohydrate Metabolism Disorder

Keywords

  • Carbohydrate restriction
  • Ketosis after bariatric surgery
03

In context

Obesity, Morbid

941 studies on the registry are indexed under Obesity, Morbid; 163 are open to participants now.

This study's planned enrollment of 150 is above the median of 62 across 602 interventional studies indexed under Obesity, Morbid.

Browse Obesity, Morbid studies →

Lead sponsor

The Society of Bariatric and Metabolic Surgeons of Kazakhstan is the lead sponsor of 8 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • obesity patients 30-50 kg/m2.
  • patients with nonalcoholic steatohepatitis (NASH).

Exclusion criteria

Exclusion Criteria:

  • patients with active physical sports
  • diabetes
  • cirrhosis
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Carbohydrate Restriction after a Gastric Bypass: 51-75% deficit in carbohydrates

    In the postoperative period, the amount of carbohydrate intake was reduced by counting carbohydrates in a glucose solution in the first three days after surgery and counting carbohydrates in food. Created a carbohydrate deficit of 51-75%.

    Other: Carbohydrate Restriction after a Gastric Bypass

  • Active comparator
    Carbohydrate Restriction after a Gastric Bypass: 26-50% deficit in carbohydrates

    In the postoperative period, the amount of carbohydrate intake was reduced by counting carbohydrates in a glucose solution in the first three days after surgery and counting carbohydrates in food. Created a carbohydrate deficit: 26-50% deficit in carbohydrates.

    Other: Carbohydrate Restriction after a Gastric Bypass

  • Active comparator
    Carbohydrate Restriction after a Gastric Bypass:1-25% deficit in carbohydrates

    In the postoperative period, the amount of carbohydrate intake was reduced by counting carbohydrates in a glucose solution in the first three days after surgery and counting carbohydrates in food. Created a carbohydrate deficit:1-25% deficit in carbohydrates.

    Other: Carbohydrate Restriction after a Gastric Bypass

Interventions

  • OtherCarbohydrate Restriction after a Gastric Bypass

    All patients will undergo laparoscopic one anastomotic gastric bypass. In the postoperative period, all patients will receive normal daily amounts of protein and fat. Depending on the amount of carbohydrates that will be received after surgery, patients will randomly (no mask) be divided into three groups: The first group: 51-75% deficit in carbohydrates Second group: 26-50% deficit in carbohydrates The third group: has a 1-25% deficit in carbohydrates.

    Also known as: laparoscopic one anastomotic gastric bypass

06

What researchers measure

Primary outcomes

  1. Cases of ketosis and incidence of ketoacidosis

    Compare the incidence of ketoacidosis and liver failure in three groups of patients with NASH with different intakes of carbohydrates in the early postoperative period after gastric bypass

    Time frame: The time frame is baseline, first 7 days, 1, 3, 6,12 months after surgery.

  2. Cases of liver failure

    Compare the incidence of liver failure in three groups of patients with NASH with different intakes of carbohydrates in the early postoperative period after gastric bypass

    Time frame: The time frame is baseline, first 7 days, 1, 3, 6,12 months after surgery.

Secondary outcomes

  1. Change in body mass index (Δ BMI)

    This measurement assesses the change in BMI after the intervention. Weight (kg) and height (cm) will be combined in the BMI (kg/m2).

    Time frame: The time frame is baseline,1, 3, 6,12 months after surgery.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Apr 2025, 12 months after the start.

Of 274 non-industry interventional studies with no phase under Obesity, Morbid, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 48. This study's planned 12 months is below that.

Counting every sponsor, half of 286 studies reached it within 25 months; a quarter within 11 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 24, 2024
First posted
Apr 1, 2024
StartActual
Mar 25, 2024
Primary completionEst.
Apr 1, 2025
CompletionEst.
Aug 1, 2025
Last update
Apr 3, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06338969
Lead sponsor
The Society of Bariatric and Metabolic Surgeons of Kazakhstan
Responsible party
Sponsor
First posted
Apr 1, 2024
Start date
Mar 25, 2024
Primary completion
Apr 1, 2025 (estimated)
Completion
Aug 1, 2025 (estimated)
Last update
Apr 3, 2024

Study contacts

Oral Ospanov, PhD
Contact
bariatric.kz@gmail.com
7015287734 ext. +7
Bakhtiyar Yelembayev
Contact
elembaevbaha@gmail.com
7071302383 ext. +7
Oral Ospanov, PhD
principal investigator · The Society of Bariatric and Metabolic Surgeons of Kazakhstan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion